Atara Biotherapeutics, Inc.
ATRA
$7.42
$0.101.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -17.84% | -34.39% | -77.03% | -77.49% | -78.70% |
| Total Receivables | -95.65% | 137.12% | 167.03% | 3,184.78% | -16.85% |
| Inventory | 9.78% | 112.11% | 138.51% | 201.20% | 511.98% |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 62.10% | 2.38% | -39.99% | -34.54% | -34.43% |
| Total Current Assets | -36.30% | -22.61% | -63.78% | -52.52% | -65.48% |
|
|
|||||
| Total Current Assets | -36.30% | -22.61% | -63.78% | -52.52% | -65.48% |
| Net Property, Plant & Equipment | -30.09% | -25.56% | -24.10% | -22.57% | -20.90% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -35.94% | -46.62% | -45.11% | -43.99% | -30.98% |
| Total Assets | -34.08% | -24.41% | -52.41% | -45.29% | -56.03% |
|
|
|||||
| Total Accounts Payable | 18.54% | -67.04% | 26.95% | -43.69% | -46.38% |
| Total Accrued Expenses | -56.32% | -52.11% | -52.91% | 0.93% | -3.72% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.27% | 10.24% | 8.07% | 11.28% | -10.71% |
| Total Finance Division Other Current Liabilities | 22.17% | 902.02% | 800.34% | 1,140.97% | 872.91% |
| Total Other Current Liabilities | 22.17% | 902.02% | 800.34% | 1,140.97% | 872.91% |
| Total Current Liabilities | -5.38% | 97.22% | 98.88% | 166.21% | 80.22% |
|
|
|||||
| Total Current Liabilities | -5.38% | 97.22% | 98.88% | 166.21% | 80.22% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -31.03% | -27.35% | -25.22% | -23.16% | -21.31% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -47.55% | -62.49% | -63.45% | -64.41% | -31.90% |
| Total Liabilities | -22.04% | -2.66% | -4.53% | 11.16% | 5.99% |
|
|
|||||
| Common Stock & APIC | 4.66% | 5.00% | 3.35% | 3.74% | 2.66% |
| Retained Earnings | -4.34% | -6.98% | -9.85% | -13.19% | -16.31% |
| Treasury Stock & Other | 103.92% | 103.85% | 98.50% | 95.55% | 90.13% |
| Total Common Equity | 1.96% | -78.09% | -1,587.36% | -251.34% | -178.36% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 1.96% | -78.09% | -1,587.36% | -251.34% | -178.36% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 1.96% | -78.09% | -1,587.36% | -251.34% | -178.36% |
|
|
|||||